ASX-Dividend-Report-Banner

I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S.

April 05, 2025 11:00 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S.
Image source: Kalkine Media

– Age-Reversed Stem Cell Technology Now Available to the Public –

PALO ALTO, Calif., April 5, 2025 /PRNewswire/ -- I Peace, Inc. (https://ipeace.com/en/), a global pioneer in iPSC (induced pluripotent stem cell) technology, proudly announces the launch of its personalized iPS cell production and longevity-focused rejuvenation therapies in the United States.

On April 5th, Koji will be speaking at the "Unlimited Health Conference," a part of the Vitalist Bay, the biggest longevity event in the world that is held in Berkeley California.

For more information, visit https://ipeace.com/en/

iPS cell technology enables the creation of age-reversed stem cells that reflect a younger version of the individual's biology. I Peace is now expanding the use of this breakthrough not only for regenerative medicine but also for a wide range of longevity applications.

Previously, clinical grade iPS cell production in one facility was limited to just one person per year, with costs reaching a few million USD. I Peace has now achieved industrial-scale manufacturing, capable of producing hundreds of iPS cell lines per year and has reduced the cost to several thousands of dollars per individual.

Conventional stem cells retain the age of the donor — a 50-year-old person's stem cells still retain the characteristics of 50 years old. In contrast, iPS cells enable the extraction of youthful cellular components, making it possible to develop therapies based on the individual's own cells but in a younger state. Scientific studies suggest that restoring youthful cellular factors may significantly promote rejuvenation and extend vitality.

With this capability, I Peace is delivering what was once impossible: personalized access to one's own age-reversed cells for use in advanced longevity and rejuvenation therapies. Furthermore, because iPS cells can differentiate into virtually any human cell, they serve as a biological backup — offering the potential to treat disease or injury in the future using the patient's own youthful cells.

I Peace now offers two core services in the U.S.:

  1. Personal iPS Cell Production & Banking – Create and preserve your own youthful stem cells while you're still healthy.
  2. Longevity & Rejuvenation Therapies – Personalized therapeutic applications using age-reversed cells and their components.

These services have already been provided to hundreds of individuals in Japan, and I Peace is now making them available to clients in the U.S.

"We aim to bring the power of iPS cell technology to everyone — so people can take charge of their own longevity and unlock a healthier, longer life," said Koji Tanabe, Founder and CEO of I Peace.

I Peace, Inc.

I Peace, Inc. provides GMP iPS cells globally and is an entrusted manufacturing service provider of various medical grade cells. The company was founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto University, and the second author of the paper that reported the successful establishment of the world's first human iPS cell line. Tanabe has been involved in iPS cell research since the early days of its development and is working daily on innovative technical developments to make iPS cells accessible to everyone through I Peace, Inc.

Our unique technology enables us to produce multiple donor-derived iPS cells in parallel without contamination concerns and to provide scalable iPS cell manufacturing at a reasonable price. We are also promoting the production of iPS cells for individuals so that everyone in the world can prepare for the future by preserving their own iPS cells.

We support drug discovery and cell medicine development by providing iPS cells and other cell products that meet PMDA and FDA standards to pharmaceutical and cell medicine development companies so that cell medicine can become available to patients as soon as possible. Our ultimate goal is to enhance the prevalence of regenerative medicine by establishing iPS cell banking services for individuals and making iPS cells accessible to other development companies working with this incredible technology.

I Peace, Inc.
Founder & CEO: Koji Tanabe
Established: 2015
Headquarters: Palo Alto, California, U.S.A.
Subsidiary in Japan: I Peace, Ltd., Kyoto
iPS cell manufacturing base: Peace Engine Kyoto, Kyoto
Website: https://ipeace.com/en/ 

 

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.